Argent BioPharma Limited
Argent BioPharma Limited (RGT.L) Stock Overview
Explore Argent BioPharma Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4.2M
P/E Ratio
-0.67
EPS (TTM)
$-0.23
ROE
4.20%
RGT.L Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Argent BioPharma Limited (RGT.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $1.80.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.67 and a market capitalization of 4.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.